DBV Technologies | DBVT - Market Capitalization


DBV Technologies reported $827.4M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amarin USD 341M 4M Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
DBV Technologies USD 274M 17M Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025